Genomelink

company

About

Genomelink is a platform where people discover more with their DNA data and help businesses build, market, and do research with it.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
¥50M
Industries
Biotechnology,Consumer Software,Genetics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it.

The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and lead bioinformatician and software engineer at a joint-venture between Illumina and Sony.

Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥50M
Genomelink has raised a total of ¥50M in funding over 2 rounds. Their latest funding was raised on Aug 22, 2017 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 22, 2017 Seed ¥50M 1 500 Global Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Genomelink is funded by 1 investors. 500 Global are the most recent investors.
Investor Name Lead Investor Funding Round
500 Global Yes Seed